We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Shimadzu Medical Systems

Manufactures analytical instruments, testing and measuring instruments and diagnostic imaging systems read more Featured Products: More products

Download Mobile App

Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape

By HospiMedica International staff writers
Posted on 27 Jun 2023
Print article
Image: The innovative AI-enhanced UV-C disinfection technology could revolutionize healthcare (Photo courtesy of Shyld)
Image: The innovative AI-enhanced UV-C disinfection technology could revolutionize healthcare (Photo courtesy of Shyld)

Healthcare-associated infection (HCAI) is a widespread complication in healthcare management, posing a significant health risk due to its potential to increase patient morbidity and mortality, prolong hospital stays, and escalate associated costs. The emergence of serious infections like Severe Acute Respiratory Syndrome (SARS) and reemerging diseases such as plague and tuberculosis has underscored the need for effective infection control across all healthcare environments. Now, an innovative artificial intelligence (AI)-enhanced UV-C disinfection technology aims to redefine the landscape of infection control.

A strategic partnership between Shimadzu Corporation (Kyoto, Japan) and Shyld (Sunnyvale, CA, USA) has resulted in the entry of the cutting-edge Shyld AI disinfection technology in the hospital infection control market. This innovation automatically detects risks in real-time and kills pathogens on various surfaces using UV-C light. Shyld AI incorporates advanced AI and optics to revolutionize indoor air and surface disinfection, safeguarding patients as well as staff. This avant-garde technology underscores the increasing role of AI in refining healthcare processes, minimizing operational costs, and addressing ongoing staff shortages.

The AI-enabled UV-C disinfection technology designed for hospitals and healthcare facilities automatically detects and assesses risks in real time. It initiates the disinfection of frequently touched surfaces immediately after a room is vacated and identifies human presence in real-time to mitigate risks. The targeted and directional disinfection considerably cuts down the time required for room disinfection, and its round-the-clock hygiene monitoring ensures no potential risk is overlooked. By eliminating germs before they can spread, the Shyld AI disinfection technology reduces the incidence of Hospital-Acquired Infections (HAI), patient readmissions, and disease transmission.

Moreover, Shyld’s intuitive and comprehensive infection monitoring tools take infection prevention to the next level. A single dashboard provides unlimited insights, enabling users to view and track all infection and disinfection reports across the organization in one location. Users can select any report for a detailed analysis of each device, building, floor, and room over time. The technology also permits users to customize their UV disinfection zones and specify unlimited stop zones within each room to protect samples or equipment from UV exposure. It allows for the creation of individual UV disinfection zones within each room, limiting the disinfection area to the desired sections.

"This new AI-powered, automatic UV-C disinfection solution is a testament to the transformative potential of artificial intelligence in revolutionizing healthcare protocols," said Hiroto Itoi, CTO of Shimadzu Corporation. "As global emphasis on health and safety escalates, our alliance with Shyld emboldens us to rewrite the narrative around disinfection protocols. By harmonizing our cutting-edge optical technology with Shyld's sophisticated AI, we're poised to roll out a game-changing UV-C disinfection solution, epitomizing Shimadzu's dedication to bolstering human health through innovative strides."

"This partnership stands as a hallmark of Shyld's mission to catalyze industrial transformation through AI. By synergizing our AI expertise with Shimadzu's optical prowess, we are not merely engineering a product but trailblazing towards a safer, healthier future," added Mohammad Noshad, CEO of Shyld.

Related Links:
Shimadzu Corporation

Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Supplier
Conductive Gel
All-Lead ECG Workstation
Dixion 1018
Treatment Light

Print article


Critical Care

view channel
Image: Flexible thin-film electrodes placed directly on brain tissue have shown promise for diagnosis and treatment of epilepsy (Photo courtesy of Tokyo Tech)

Thin-Film Neural Electrodes Placed Directly on Brain Tissue Can Diagnose and Treat Epilepsy

Analyzing brain activity is crucial for diagnosing conditions like epilepsy and other mental health disorders. Among various methods, electroencephalography (EEG) is considered the least intrusive, using... Read more

Surgical Techniques

view channel
Image: The ARC-IM Stimulator with brain-computer interface restores arm, hand, and finger function after spinal cord injury (Photo courtesy of ONWARD Medical)

First-in-Human Implant of Thought-Driven Movement Device to Treat Spinal Cord Injury

In order to walk, signals from the brain are sent to neurons in the lumbosacral part of the spinal cord. When a spinal cord injury occurs, it cuts off this essential communication between the brain and... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The broad-spectrum POC coagulometer is well-suited for emergency room and emergency vehicle use (Photo courtesy of Perosphere)

Novel POC Coagulometer with Lab-Like Precision to Revolutionize Coagulation Testing

In emergency settings, when patients arrive with a bleed or require urgent surgery, doctors rely solely on clinical judgment to determine if a patient is adequately anticoagulated for reversal treatment.... Read more


view channel
Image: The global surgical lights market is expected to grow by close to USD 0.50 billion from 2022 to 2027 (Photo courtesy of Freepik)

Global Surgical Lights Market Driven by Increasing Number of Procedures

The global surgical lights market is set to witness high growth, largely due to the increasing incidence of chronic illnesses, a surge in demand for cosmetic and plastic surgeries, and untapped opportunities... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.